Aridis Pharmaceuticals In... (ARDS)

0.00

-0.00 (-100.00%)

At close: Feb 28, 2025, 9:52 AM

0.00

-99.00%

Pre-market: Oct 07, 2024, 09:30 AM EDT

Aridis Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-30.37M	-42.19M	-22.33M	-29.68M	-22.11M	-24.66M	-8.42M
Depreciation & Amortization	487K	435K	337K	338K	283K	62K	23K
Stock-Based Compensation	1.48M	2.25M	2.13M	2.01M	1.66M	1.61M	858K
Other Working Capital	2.63M	7.86M	-534K	19.58M	-97K	120K	180K
Other Non-Cash Items	577K	6.78M	9K	951K	-1.59M	5.15M	369K
Deferred Income Tax	n/a	-722K	n/a	n/a	n/a	n/a	172K
Change in Working Capital	-1.3M	10.52M	-617K	18.22M	-2.52M	277K	909K
Operating Cash Flow	-29.13M	-22.94M	-20.48M	-8.16M	-24.27M	-17.56M	-6.09M
Capital Expenditures	-82K	-530K	-367K	-174K	-677K	-698K	-15K
Acquisitions	n/a	n/a	n/a	n/a	-1M	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-1M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	1M	n/a	n/a
Investing Cash Flow	-82K	-530K	-367K	-174K	-1.68M	-698K	-15K
Debt Repayment	3.2M	5M	715K	n/a	n/a	n/a	-300K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	-4.13M	n/a	n/a	-1.36M	n/a	n/a
Other Financial Acitivies	-1.03M	4.13M	14K	35K	1.37M	21.06M	25.8M
Financial Cash Flow	14.78M	34.72M	8.68M	4.99M	25.09M	21.06M	25.5M
Net Cash Flow	-14.43M	11.25M	-12.16M	-3.34M	-859K	2.81M	19.4M
Free Cash Flow	-29.21M	-23.47M	-20.84M	-8.33M	-24.95M	-18.25M	-6.11M